Compare ARK Genomic Revolution ETF (ARKG) vs Burlington Stores Inc (BURL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Burlington Stores Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Burlington Stores Inc trades at $327.72 (market cap $20.63B). Which is the better fit depends on your goals.
| ARKG | BURL | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $347.82 |
52-Week Low | $23.09 | $242.43 |
Market Cap | — | $20.63B |
Enterprise Value | — | $25.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Burlington Stores (BURL) trades at $327.72, up 1.95% today, with strong technical momentum and consistent earnings beats. The stock shows bullish moving averages and is near its 52-week high. Recent quarters have exceeded EPS expectations, with Q1 2026 actual EPS of $2.01 beating the $1.80 estimate. Financials reveal robust revenue growth, with 2025 revenue at $10.63B and net income of $503.64M, while analyst sentiment remains overwhelmingly positive with 94% buy ratings.
BURL's outlook is favorable, driven by margin expansion and store productivity gains, but risks include high valuation multiples and competitive retail pressures. The consensus price target of $364.40 suggests upside potential, though investors should monitor debt levels and consumer spending trends for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Burlington Stores Inc
Burlington is a leading off-price retailer in the US, offering branded apparel, footwear, and home goods at significant discounts. It operates hundreds of stores focused on delivering high-quality products at great value.
Read more on BURL →
